financetom
Business
financetom
/
Business
/
BRIEF-SPAC Cantor Equity Partners To List Class A Ordinary Shares On Nasdaq Global Market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-SPAC Cantor Equity Partners To List Class A Ordinary Shares On Nasdaq Global Market
Jul 26, 2024 3:21 PM

July 26 (Reuters) -

Cantor Equity Partners:

* CANTOR EQUITY PARTNERS, INC.: INTEND TO APPLY TO LIST

CLASS A

ORDINARY SHARES ON NASDAQ GLOBAL MARKET, OR NASDAQ, UNDER THE

SYMBOL "CEP".

Source text for Eikon:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bank of Montreal warns of loss provision pressures after profit miss, shares fall
Bank of Montreal warns of loss provision pressures after profit miss, shares fall
Aug 29, 2024
TORONTO, Aug 27 (Reuters) - Bank of Montreal ( BERZ ) on Tuesday warned it would need to continue to set aside money for loans that are unlikely to be repaid, after the Canadian lender reported lower-than-expected profit for the sixth time in a row. The lender however said it would start to see a recovery in 2025 as central...
Amazon.com Launches AI Shopping Assistant Rufus in India
Amazon.com Launches AI Shopping Assistant Rufus in India
Aug 29, 2024
11:13 AM EDT, 08/27/2024 (MT Newswires) -- Amazon.com ( AMZN ) said Monday that it launched a beta version of its artificial intelligence-backed shopping assistant Rufus in India. The e-commerce giant said Rufus is trained on its product catalog and information from the internet, allowing the AI assistant to compare products, provide product recommendations, and answer customers' questions on shopping...
Legend Biotech Says China's National Medical Products Administration Approves Cell Therapy Product to Treat Multiple Myeloma
Legend Biotech Says China's National Medical Products Administration Approves Cell Therapy Product to Treat Multiple Myeloma
Aug 29, 2024
11:13 AM EDT, 08/27/2024 (MT Newswires) -- Legend Biotech ( LEGN ) said Tuesday that China's National Medical Products Administration has approved the company's cell therapy product ciltacabtagene autoleucel to treat adult patients with relapsed or refractory multiple myeloma, who received at least three previous lines of therapy. Ciltacabtagene autoleucel, or cilta-cel, is a gene-modified therapy targeting B-cell maturation antigen...
Brown-Forman's 'Hangover Continues' Amid US Headwinds, RBC Says
Brown-Forman's 'Hangover Continues' Amid US Headwinds, RBC Says
Aug 29, 2024
11:13 AM EDT, 08/27/2024 (MT Newswires) -- Brown-Forman's (BF.B) hangover continues amid US headwinds and muted performance in key brands, RBC Capital Markets said Tuesday in a report. We see near term pressures continuing to weigh on numbers despite easier compares ahead, partly on slowing consumption outside the US, RBC said. Brown-Forman will announce fiscal Q1 results on Thursday. The...
Copyright 2023-2025 - www.financetom.com All Rights Reserved